• Cabozanix (Cabozantinib 20,60,80mg):Targeted Therapy for CancerCabozanix (Cabozantinib 20,60,80mg):Targeted Therapy for Cancer Quick View
    • Cabozanix (Cabozantinib 20,60,80mg):Targeted Therapy for CancerCabozanix (Cabozantinib 20,60,80mg):Targeted Therapy for Cancer Quick View
    • Cabozanix (Cabozantinib 20,60,80mg):Targeted Therapy for Cancer

    • Cabozanix (Cabozantinib) is a cutting-edge oral medication designed to treat advanced stages of various cancers, including renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and medullary thyroid cancer (MTC). As a tyrosine kinase inhibitor (TKI), Cabozantinib blocks specific proteins that drive the growth and spread of cancer cells. Available in 20 mg, 60 mg, and 80 mg strengths, Cabozanix is a…
    • Read more
  • Lenvaxen 4 mg & 10 mg (Lenvatinib)Lenvaxen 4 mg & 10 mg (Lenvatinib) Quick View
    • Lenvaxen 4 mg & 10 mg (Lenvatinib)Lenvaxen 4 mg & 10 mg (Lenvatinib) Quick View
    • , ,
    • Lenvaxen 4 mg & 10 mg (Lenvatinib)

    • Lenvaxen (Lenvatinib) is a powerful oral medication used to treat various types of cancer, including thyroid cancer, renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC). The active ingredient in Lenvaxen is lapatinib, a tyrosine kinase inhibitor (TKI) that works by blocking multiple enzymes responsible for the growth and spread of cancer cells. This targeted approach helps slow down tumour growth,…
    • Read more